Why the study?
Does real-life lipid-lowering therapy achieve LDL cholesterol goals in very high-risk patients with coronary artery disease?
Does real-life lipid-lowering therapy achieve LDL cholesterol goals in very high-risk patients with coronary artery disease?
In real-world practice in France, more than half of very high-risk patients with coronary artery disease do not achieve their LDL cholesterol goals, highlighting a significant gap in secondary prevention.
Real-world LDL goal attainment falls short in over half of very high-risk CAD patients; leaves open effective implementation strategies for secondary prevention.
These real-world results show that lipid control in very high-risk patients remains insufficient. More than half of the patients did not achieve the LDL cholesterol goal. Prevention of cardiovascular events in these very high-risk patients could be further improved by better education and more intensive lipid-lowering therapy.
No takes yet. Share an insight, caveat, or question.
Ferrières et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: